↓ Skip to main content

Inhibition of West Nile Virus Multiplication in Cell Culture by Anti-Parkinsonian Drugs

Overview of attention for article published in Frontiers in Microbiology, March 2016
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
googleplus
1 Google+ user
reddit
1 Redditor

Readers on

mendeley
51 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Inhibition of West Nile Virus Multiplication in Cell Culture by Anti-Parkinsonian Drugs
Published in
Frontiers in Microbiology, March 2016
DOI 10.3389/fmicb.2016.00296
Pubmed ID
Authors

Ana B. Blázquez, Miguel A. Martín-Acebes, Juan-Carlos Saiz

Abstract

West Nile virus (WNV) is a mosquito-borne flavivirus maintained in a transmission cycle between mosquitoes and birds, but it can also infect other vertebrates, including humans, in which it can cause neuroinvasive diseases. To date, no licensed vaccine or therapy for human use against this pathogen is yet available. A recent approach to search for new antiviral agent candidates is the assessment of long-used drugs commonly administered by clinicians to treat human disorders in drug antiviral development. In this regard, as patients with West Nile encephalitis frequently develop symptoms and features of parkinsonism, and cellular factors altered in parkinsonism, such as alpha-synuclein, have been shown to play a role on WNV infection, we have assessed the effect of four drugs (L-dopa, Selegiline, Isatin, and Amantadine), that are used as therapy for Parkinson's disease in the inhibition of WNV multiplication. L-dopa, Isatin, and Amantadine treatments significantly reduced the production of infectious virus in all cell types tested, but only Amantadine reduced viral RNA levels. These results point to antiparkinsonian drugs as possible therapeutic candidates for the development of antiviral strategies against WNV infection.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 2%
Unknown 50 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 20%
Student > Ph. D. Student 9 18%
Researcher 7 14%
Student > Bachelor 4 8%
Student > Doctoral Student 3 6%
Other 8 16%
Unknown 10 20%
Readers by discipline Count As %
Agricultural and Biological Sciences 10 20%
Chemistry 6 12%
Immunology and Microbiology 3 6%
Neuroscience 3 6%
Biochemistry, Genetics and Molecular Biology 3 6%
Other 11 22%
Unknown 15 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 May 2016.
All research outputs
#14,252,924
of 22,854,458 outputs
Outputs from Frontiers in Microbiology
#12,446
of 24,862 outputs
Outputs of similar age
#157,540
of 298,965 outputs
Outputs of similar age from Frontiers in Microbiology
#302
of 544 outputs
Altmetric has tracked 22,854,458 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 24,862 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.3. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 298,965 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 544 others from the same source and published within six weeks on either side of this one. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.